TGA

clinical-trials-medicinal-cannabis-studies

Clinical Trials: Setting up Your Cannabis Research Study

There is widespread demand for access to medicinal cannabis products by patients. Yet very few Australian doctors currently prescribe cannabinoid-derived medications. Will emerging clinical trial evidence reduce the reluctance of GPs to prescribe these …

medicinal cannabis products

TGA GMP Manufacturing licence for Medicinal Cannabis

This blog is intended as a current guide how to set about applying for a TGA GMP Manufacturing license for Medicinal Cannabis.
Process for applying for a TGA GMP Manufacturing Licence
Two Manufacturing Licences may be …

Updates to TGA fees and charges

Every year the TGA undertakes a comprehensive targeted consultation by engaging with peak therapeutic industry bodies in regard to the fees and charges proposal for the upcoming financial year.

The TGA is required to recover …

TGA issues new Australian Complementary Medicine Guidelines

Previously we wrote about the TGA planning to revise the complementary medicine guidelines. On the 13 October 2016 the Australian TGA released the sixth version of the Australian regulatory guidelines for complementary medicines ARGCM, Version 6.0, October …